Skip to main content
High RiskFDAfda-F-1402-2014OTHER

Hot Smoked Pepper Atlantic Salmon, Item HS-C, vacuum packaged and either frozen or refrigerated, ranging in size between about one poun...

Category
Units Affected
5
Recall Date
November 27, 2013
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1402-2014.

The hot smoked fisheries products in vacuum packages were undercooked and it has a potential hazard of Clostridium botulinum toxin formation.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1402-2014.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Josephson's Smokehouse or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1402-2014.

Josephson's Smokehouse

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Josephson's Smokehouse Recall FAQ

Josephson's Smokehouse is the subject of a seafood safety report: Hot Smoked Pepper Atlantic Salmon, Item HS-C, vacuum packaged and either frozen or refrigerated, ranging in size between about one poun.... The notice was published on November 27, 2013 by the U.S. Food and Drug Administration (FDA). Approximately 5 units are potentially affected.